Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Helicobacter pylori Genotypes Associated with Gastric Histo-Pathological Damages in a Moroccan Population

  • Samia Alaoui Boukhris,

    Affiliations Laboratoire de Microbiologie et Biologie Moléculaire, Equipe micro-organismes et facteurs oncogènes, Faculté de médecine et de Pharmacie de Fès (FMPF), Université Sidi Mohammed Ben Abdellah (USMBA), Fès, Maroc, Laboratoire de Biotechnologie, Faculté des sciences Dhar el Mehraz, USMBA, Fès, Maroc

  • Afaf Amarti,

    Affiliations Service d’Anatomie pathologique CHU Hassan II, Fès, Maroc, Laboratoire de Biologie des cancers, FMPF, USMBA, Fès, Maroc

  • Karima El Rhazi,

    Affiliation Laboratoire d’Epidémiologie et de recherche clinique, FMPF, USMBA, Fès, Maroc

  • Mounia El Khadir,

    Affiliations Laboratoire de Microbiologie et Biologie Moléculaire, Equipe micro-organismes et facteurs oncogènes, Faculté de médecine et de Pharmacie de Fès (FMPF), Université Sidi Mohammed Ben Abdellah (USMBA), Fès, Maroc, Laboratoire de Biotechnologie, Faculté des sciences Dhar el Mehraz, USMBA, Fès, Maroc

  • Dafr-Allah Benajah,

    Affiliations Service d’Hépato gastro-entérologie CHU Hassan II de Fès, Equipe Maladies de l’appareil digestif (FMPF), Fès, Maroc, Laboratoire de Biologie des cancers, FMPF, USMBA, Fès, Maroc

  • Sidi Adil Ibrahimi,

    Affiliations Service d’Hépato gastro-entérologie CHU Hassan II de Fès, Equipe Maladies de l’appareil digestif (FMPF), Fès, Maroc, Laboratoire de Biologie des cancers, FMPF, USMBA, Fès, Maroc

  • Chakib Nejjari,

    Affiliation Laboratoire d’Epidémiologie et de recherche clinique, FMPF, USMBA, Fès, Maroc

  • Mustapha Mahmoud,

    Affiliations Service de Bactériologie CHU Hassan II, Fès, Maroc, Laboratoire de Biologie des cancers, FMPF, USMBA, Fès, Maroc

  • Abdellah Souleimani,

    Affiliation Laboratoire de Biotechnologie, Faculté des sciences Dhar el Mehraz, USMBA, Fès, Maroc

  • Bahia Bennani

    * Email: bahia_bc@yahoo.fr

    Affiliations Laboratoire de Microbiologie et Biologie Moléculaire, Equipe micro-organismes et facteurs oncogènes, Faculté de médecine et de Pharmacie de Fès (FMPF), Université Sidi Mohammed Ben Abdellah (USMBA), Fès, Maroc, Laboratoire de Biotechnologie, Faculté des sciences Dhar el Mehraz, USMBA, Fès, Maroc, Laboratoire de Biologie des cancers, FMPF, USMBA, Fès, Maroc

Abstract

H. pylori persistent infection induces chronic gastritis and is associated with peptic ulcer disease and gastric carcinoma development. The severity of these diseases is related to human’s genetic diversity, H. pylori genetic variability and environmental factors. To identify the prevalence of histo-pathological damages caused by H. pylori infection in Moroccan population, and to determine their association to H. pylori genotypes, a prospective study has been conducted during 3 years on patients attending the gastroenterology department of Hassan II University Hospital (CHU) of Fez, Morocco. A total of 801 Moroccan adults’ patients were recruited; H. pylori was diagnosed and genotyped by PCR in biopsy specimens and histological exam was performed. We found a high rate of glandular atrophy. Chronic inflammation, neutrophil activity and glandular atrophy showed statistically significant association with H. pylori infection. However, intestinal metaplasia was inversely associated to this infection and no association was observed with gastric cancer cases. A statistically significant association was found between intestinal metaplasia and vacAs1 and vac Am1 genotypes in patients aged 50 years and more but not in younger. This last genotype is also associated to gastric cancer. In this study, gastric cancer showed no significant association with H. pylori. Further studies are warranted to determine the role of other etiological agents such as Epstein-Barr virus, human papillomavirus and possibly environmental and dietetic factors in the occurrence of this pathology.

Introduction

Helicobacter pylori (H. pylori) infection affects almost half of the world’s population. The persistent infection induces chronic inflammation of the gastric mucosa and peptic ulcers. H. pylori is also a major risk factor for gastric cancer [1,2]. The severity of the disease is related to human genetic diversity, environmental factors and H. pylori genetic variability [3]. VacA gene encodes a vacuolating cytotoxin which is excreted by H. pylori and leads to epithelial cells damages. This gene is present in all strains, and comprises variable regions (s, m and i). The s region (encoding the signal peptide) exists as s1 or s2 allele. The m region (middle) occurs as m1 or m2 allele. The mosaic combination of s and m allelic types determines the level of cytotoxin produced which has been associated to pathogenicity of the bacterium [4]. The cagA gene (cytotoxin-associated gene) is considered a marker of the pathogenicity island gene (cag PAI) presence. Infection with H. pylori cagA+ strains has been associated with an increased risk of atrophic gastritis and gastric cancer development [4]. In Morocco, there is no published data regarding the occurrence of histo-pathological damages and their correlation with H. pylori genotypes. The aim of this study is to determine the prevalence of different histopathological lesions, especially the premalignant ones, in infected patients and their correlation to H. pylori infection and also with vacA genotypes and cagA status.

Materials and Methods

Sample collection

Between May 2009 and January 2013, we recruited all the patients aged 15 years and more, attending the Gastroenterology Department of Hassan II University Hospital of Fez and undergoing endoscopy for diagnosis of abdominal pain or discomfort. All patients aged below 15 years or who were on medications (antibiotics, proton pump inhibitors) for the last 3 months, as well as pregnant or nursing women were excluded from this study. Consenting patients had a personal interview before endoscopy. Parental consent was obtained on the behalf of the participants under the age of 18. In the case of illiterate or semi-literate patients, the written consent was read to them by the interviewer.

In each participant, six biopsies samples were taken from the antrum and the middle body and used for molecular diagnosis of H. pylori and also for histo-pathological exam. Four gastric biopsies (2 fundic and 2 antral) from each subject were fixed in buffered formalin (10%) and stained with hematoxyline-eosin and Giemsa. Histopathological evaluation of samples from both settings was performed according to the Modified Sydney system [5] by at least two experimented pathologists. Gastric cancer cases have been classified as adenocarcinoma, signet ring cell carcinoma (SRCC), undifferentiated carcinoma and Malt lymphoma. Presence or absence of H. pylori on gastric biopsies was performed on histological slides and scored in a semi quantitative approach from 1+ to 3+ depending on the amount of germs in glandular crypts.

H.pylori molecular diagnosis and genotyping

H. pylori DNA extraction was done on two gastric antral biopsies as previously described [6]. Diagnosis of H. pylori was done by PCR using glmM primers [7]; all positives specimens were subjected to PCR using genotype specific primers. cag A status and vacA genotypes were determined by multiplex PCR using primers and conditions previously described to amplify cag A and the signal (s) and middle (m) regions of vac A [8,9]. PCR using a second primer pair was done to determine cag A status as previously described [10] and cag PAI empty site PCR was used to confirm this status [11]. Separately, both positive and negative controls were included. The PCR products were resolved in 2% agarose gel, stained with ethidium bromide and visualized under an UV source. The strains were considered cagA positive when at least one of the cagA reactions was positive and cagA PAI PCR was negative.

Statistical analysis

Statistical analysis was performed using SPSS software (Statistical Product and Services Solutions, version 17, SPSS Inc, Chicago, Il, USA) to analyze data. In univariate analysis, potential explicative factor for gastric damages was determined; and association between gastric lesions and genotypes was tested independently in two groups, defined according to age group (patients aged less than 50 years were grouped in age group1 and those within 50 years and older in age group 2). All Chi2 test results with P-values less than 0.05 were considered statistically significant.

This prospective study was approved by the Ethical Committee of the University Hospital of Fez.

Results

Studied population

A total of 801Moroccan adult patients were recruited in this prospective study (424 men [52.93%], and 337 women [47.07%]), aged between 15 and 99 years with mean age of 49.2 years (Standard Deviation [SD] 16.3 years). The percentage of patients with persistent exposure to smoking (active or passive) was 26.10% (202/774) whilst an 8.9% reported consumption of alcohol. Approximately two-thirds of recruited patients (n=509/780; 65.3%) were from urban areas.

Molecular diagnosis showed that 63.13% of women were H. pylori infected versus 56.6% of men (p=0.06). This infection was significantly higher in patients aged 50 years and less (66.93%) than in older ones (53.19%) (p=0.00007). No association was found between H. pylori infection and area, tobacco smoking or alcohol consumption (Table 1).

H. pylorip valueTotal
Positive n (%)Negative n (%)n (%)
GenderMen 240/424 (56.6)184/424 (43.4)0.06424/801 (52.9)
Women 238/377 (63.1)139/377 (36.9)377/801 (47.1)
Age<50253/378 (66.9)125/378 (33.1)0.00007378/801 (47.2)
>50225/423 (53.2)198/423 (46.8)423/801 (52.8)
AreaUrban309/509 (60.7)200/509 (39.3)0.5509/780 (65.3)
Rural158/271 (58.3)113/271 (41.7)271/780 (34.7)
Tobacco smokingYes 130/204 (63.7)74/204 (36.3)0.19204/780 (26.2)
No 337/576 (58.5)239/576 (41.5)576/780 (73.8)
AlcoholYes 37/69 (53.6)32/69 (46.4)0.2669/780 (8.8)
No 430/711(60.5)281/711(39.5)711/780 (91.2)
Total478/801 (59.7)323/801 (40.3)

Table 1. H. pylori status associated to risk factors.

CSV
Download CSV

CagA status and vacA s and m regions genotypes were determined for all positive specimens. As reported in table 2, 59.6% of cases were cagA positives and vacA single allele (s or m) (31.27%) is the most predominant profile followed by vacA s2m2 (29.28%) subtype. The vacA s2m1 subtype has been observed in 4 cases. When considering each genotype separately, s2 and m2 were the most predominant genotypes and were detected in 51.74% and 64.23% cases, respectively.

Genotype Subtypen (%)
Vac As1m181/478(16.9)
s1m233/478(6.9)
s2m14/478(0.8)
s2m2118/478(24.7)
Single s/m126/478 (26.4)
Multiple41/478(8.6)
Not genotyped75/478(15.7)
s1166/344 (48.3)
s2178/344 (51.7)
m198/274 (35.8)
m2176/274 (64.2)
Cag APositive248/416(59.6)
Negative 168/416(40.4)

Table 2. H. pylori genotypes description.

CSV
Download CSV

The histological exam carried out on 791 specimens, showed a high prevalence of chronic inflammation (CI) (91.51%, n=724/791), glandular atrophy (GA) (81.42%, n=644/791) and neutrophil activity (NA) (73.9%, n=585/791). Lesions known as pre-neoplastic such intestinal metaplasia (IM) and dysplasia were detected in 14.66% (116/791) and 1.52% (12/791) cases respectively. However, gastric cancer (GC) was diagnosed in 6.19% (49/ 791) cases with predominance of a signet ring cell carcinoma (SRCC) (41.67%, n=20/48), followed by adenocarcinoma (37.5%, n=18/48)) and finally by MALT lymphoma (20.38%, n=10/48). H. pylori was detected in 63.7% cases using histopathology.

Gastric lesions and associated risk factors

Tissue damages were correlated with age, gender, area, tobacco smoking, alcohol consumption and H. pylori infection. The results showed that all lesions types were predominant in patients aged more than 50 years old with significant association in GA, IM and GC cases (p<0.05). Statistically significant association was also found between gender and IM with predominance in men (18.9% vs 9.9% in women) (p=0.0002). The same tendency was observed in gastric cancer, but the association did not reach statistical significance (Table 3).

CINAGAIMGCTotal
Age <50 y340/372(91.4)278/372(74.7)293/372(78.8)38/372(10.2)17/372(4.6)378/801(47.2)
>50 y384/419(91.6)307/419(73.3)351/419(83.8)78/419(18.6)32/419(7.6)423/801(52.8)
p value0.50.340.040.00050.04
GenderMale389/418(93.1)310/418(74.2)339/418(81.1)79/418(18.9)30/418(7.2)424/801(52.9)
Female335/373(89.8)275/373(73.7)305/373(81.8)37/373(9.9)19/373(5.1)377/801(47.1)
p value0.060.470.440.00020.14
SmokingYes189/200(94.5)159/200(79.5)157/200(78.5)31/200(15.5)16/200(8)204/780(26.2)
No514/570(90.2)411/570(72.1)471/570(82.6)81/570(14.2)32/570(5.6)576/780(73.8)
p value0.030.020.10.360.15
Alcohol Yes64/68(94.1)49/68(72.1)52/68(76.5)12/68(17.6)5/68(7.4)69/780(8.8)
No639/702(91)521/702(74.2)576/702(82.1)100/702(14.2)43/702(6.1)711/780(91.2)
p value0.270.390.160.270.42
Living areaRural247/265(93.2)198/265(74.7)230/265(86.8)47/265(17.7)22/265(8.3)271/780(34.7)
Urban456/505(90.3)372/505(73.7)398/505(78.8)65/505(12.9)26/505(5.1)590/780(65.3)
p value0.100.410.0030.040.06
H.pylori*Positive440/473 (93)375/473(79.3)399/473(84.4)50 /473(10.6)25/473(5.3)478/801(59.7)
Negative284/318(89.3)210/318 (66)245 /318(77)66 /318(20.8)24/318(7.5)323/801(40.3)
p value0.040.000020.0060.000060.12

Table 3. Gastric damages and risk factors.

* H.pylori PCR result
CSV
Download CSV

Tobacco smoking was statistically significantly associated with CI and NA. However, no association was observed between alcohol consumption and histological damages. Histological pattern was associated with the area of residence. Patients from rural areas had a higher rate of GA (p=0.003) and/or IM (p=0.04) compared to those from urban areas. The same trend was observed in GC cases but the analysis had weak statistical significance (p=0.06) (Table 3).

On the basis of PCR results, the association of H. pylori infection and tissue damages was verified. As reported in Table 1, H. pylori was positively associated to CI, NA and GA and negatively associated with IM. H. pylori infection was detected most frequently in patients with SRCC than ADK and Malt lymphoma with rates of 60%, 55.6% and 20% respectively.

H. pylori genotypes and gastric damages

After adjustment for age, we found a statistically significant association between H. pylori infection and CI, GA, NA in patients aged less than 50 years. An association was also found between H pylori and severe lesions (GA and metaplasia) in individuals aged 50 years or more (Table 4).

<50 ans>50 ans
Chronic inflammationChronic inflammation
Yes No pYes No p
PCRPositive69.1 (235/340)43.8 (14/32)0.00353.4 (205/384)54.3 (19/35)0.9
Cag APositive 65 (132/203)50 (6/12)0.2954.4 (98/180)58.82 (10/17)0.72
VacAss152.3 (92/176)22.2 (2/9)0.0743.2 (60/139)62.5 (10/16)0.1
s247.7 (84/176)77.8 (7/9)56.8 (79/139)37.5 (6/16)
VacAmm140.1 (57/142)14.3 (1/7)0.1730.9 (34/110)41.7 (5/12)0.44
m259.9(85/142)85.7 (6/7)69.1 (76/110)58.3(7/12)
Neutrophil activityNeutrophil activity
YesNopYesNop
PCRPositive71.6 (199/278)53.2 (50/94)0.00157.3 (176/307)42.9 (48/112)0.008
Cag APositive68.4 (119/174)46.3 (19/41)0.00855.8 (86/154)51.2 (22/43)0.58
VacAss154.6 (83/152)33.3 (11/33)0.0246 (58/126)41.4 (12/29)0.64
s245.4 (69/152)66.7(22/33)54(68/126)58.6 (17/29)
VacAmm141.2 (54/131)22.2 (4/18)0.1229.2 (28/96)42.3 (11/26)0.202
m258.8 (77/131)77.8 (14/18)70.8 (68/96)57.7 (15/26)
Glandular atrophyGlandular atrophy
YesNopYesNop
PCRPositive68.6 (201/293)60.8 (48/79)0.1856.4 (198/351)38.8 (26/68)0.006
Cag APositive 63.7 (109/171)65.9 (29/44)0.7853.1 (93/175)68.2 (15/22)0 .181
VacAss149.3 (74/150)57.1 (20/35)0.444.6 (62/139)50 (8/16)0.68
s250.7 (76/150)42.9 (15/35)55.4 (77/139)50 (8/16)
VacAmm140.7 (50/123)30.8 (8/26)0.3429.3 (32/109)53.8 (7/13)0.073
m259.3 (73/123)69.2 (18/26)70.6 (77/109)46.2 (6/13)
Intestinal metaplasiaIntestinal metaplasia
YesNopYesNop
PCRPositive55.3 (21/38)68.3 (228/334)0.137.2 (29/78)57.2 (195/341)0.001
Cag APositive 70 (14/20)63.6 (124/195)0.5650 (14/28)55.6 (94/169)0.57
VacAss142.9 (6/14)51.5 (88/171)0.5370 (14/20)41.5 (56/135)0.016
s257.1 (8/14)48.5 (83/171)30 (6/20)58.5 (79/135)
VacAmm146.2 (6/13)38.2 (52/136)0.5753.3 (8/15)29 (31/107)0.058
m253.8 (7/13)61.8 (84/136)46.7 (7/15)71 (76/107)
CancerCancer
YesNopYesNop
PCRPositive64.7 (11/17)67 (238/355)0.843.8 (14/32)54.3 (210/387)0.2
Cag APositive 54.5 (6/11)64.7 (132/204)0.4983.3 (10/12)53 (98/185)0.04
VacAss150 (4/8)50.8 (90/177)0.9666.67 (8/12)43.4 (62/143)0.11
s250 (4/8)49.2 (87/177)33.33 (4/12)56.6 (81/143)
VacAmm142.86 (3/7)38.7 (55/142)0.8260 (6/10)29.5 (33/112)0.04
m257.14 (4/7)61.3 (87/142)40 (4/10)70.5 (79/112)

Table 4. H. pylori Genotypes associated to gastric damages in age groups 1 and 2.

Values were expressed % (n).
CSV
Download CSV

Most patients with positive H. pylori (93%) also had chronic inflammation (p=0.04). When stratified by age, 69.12 % of patients with this lesion were H. pylori positives in age group 1 (p=0.003). However, no statistically significant association was observed in the age group 2. VacA and cagA genotypes showed no association to this histological profile.

In patients with NA, H. pylori was detected in 64.1% cases (p=0.00003) with 71.6% cases in age group 1 and 57.3% in age group 2. Those associations were significant with p value of 0.001 and 0.008, respectively. This histological profile showed a significant association with cagA+ and also with vac A s1 genotype in age group 1. However, no association was found between NA and H. pylori genotypes in age group 2. In patients with GA, H. pylori was detected in 62% cases (p=0.005) with rate of 68.6% in age group 1 and 56.4% in age group 2, the latter being statistically significant (p=0.006). Nevertheless, no association was found between GA and the various H. pylori genotypes.

For severe lesions, H. pylori was detected in 43.1% (p= 0.00007) of IM cases and in 51.02% of GC cases (p=0.19). The negative association between H. pylori and IM was statistically significant in age group 2 with a rate of 37.2% (29/78) (p=0.001). In this age group and for the same lesion, a statistically significant association was found with vac As1 genotype (vs s2) (p=0.016) and with vac A m1 genotype (vs m2) (p=0.058).

In cancer cases, a statistically significant association was detected with cagA + (p= 0.04) and vac A m1 genotype (vs m2) (p=0.04) in age group 2. In this age group, two third of cancer cases H.pylori infected were vac As1 but the association did not reach statistical significant value (p=0.1) (Table 4). When studying association of H .pylori genotypes with GC types, vacA s1 and m1 subtypes were more predominant in SRCC type with 63.6% and 71.4% respectively, versus 42.9% and 42.9% in adenocarcinoma cases, respectively. However, H. pylori cagA positive strains were predominant in both types (63.6% in SRCC and 66.7% in adenocarcinoma cases).

Discussion

In this prospective study, 801 gastric biopsies samples were analyzed by histopathology and PCR. This last technique has been described in several studies as more sensitive and convenient reproducible method than histopathology [12]. For this reason, the results of H. pylori molecular diagnosis were used to study different associations. The interest of histopathology is the fact that it offers the possibility to detect epithelial gastric damages, to classify them in different categories and to assess their severity. Moreover it is the only way to detect high risk lesions or in some cases the presence of associated invasive carcinoma [12-15].

H. pylori induces chronic gastritis in virtually all infected patients. This gastritis leads to more sever gastric pathologies, notably, peptic ulcer disease, atrophic gastritis and gastric cancer [16]. The progress of disease seems to depend on bacterial genotypes, host and environmental factors. Some studies have reported a significant correlation between H. pylori genotypes and gastric histological damages [17-19]; whilst others reported a variability of genotypes distribution according to nationalities or geographical area [20]. To our knowledge, this is the first study conducted in North Africa and in Morocco on the association of H. pylori genotypes with gastric histological profiles. We decided a priori to divide our studied population in two groups according to their age for several reasons. Firstly, H. pylori is contracted in childhood; and secondly, a loss of glands, resulting in multifocal atrophic gastritis can lead to the development of intestinal metaplasia and dysplasia and are linked to prolonged infection and consequently to patients’ age.

In our study, H. pylori was statistically significantly associated with CI, NA and GA but negatively with IM. These results (except the negative association with IM) confirm those obtained by Kalebi et al. reporting causal association of H. pylori with CI, NA and GA [21]. The natural history of gastric lesions begins with H. pylori infection leading to chronic gastritis that can progress to more severe lesions even in the absence of bacteria [22,23]. This hypothesis could explain, in part, the failure of H. pylori detection in severe lesions and also the negative association of this infection with IM. It’s also of interest to note that in our GC series, H. pylori has been detected with lower rates (57.5%) than those reported in Brazil (93%), USA (84.4%), neighboring North African country “Libya” (63.2%) and also than the mean rate reported in developed countries (61.5%) [1,24-26]. However, the number of cancer cases in this series is too low to confirm these results. The implication or causal association of virus with gastric carcinogenesis is plausible factor to explain the failure on H. pylori detection in some GC cases in our series. In effect, several studies have reported the implication of Epstein-Barr virus (EBV) in nearly 10% of gastric cancer cases [27-31] and Human papillomavirus (HPV) in other cases, particularly in India [32]. Therefore, the implication of those micro-organisms must be verified.

It has been well established that gastritis is the first lesion observed after H. pylori infection. This data can explain the statistically significant association of H. pylori with CI and NA (regardless of genotype) in the age group 1. Such association is lost in severe lesions (GA, IM and GC). Remarkably, H. pylori infection was significantly associated to those severe lesions in age group 2 (positively with GA and negatively with IM). It was hypothesized that patients exposed to long time infection with more virulent genotypes was at risk to develop atrophic gastritis and eventually gastric cancer via metaplasia. In spite of discrepancy on this subject, most studies report an association of vacA s1, vacA m1 and cagA+ genotypes with greater gastric epithelial damages and especially with GC [17,18,22,33-35]. This can be confirmed by the results obtained with the age group 2 in our study. A significant association between vac Am1 (p=0.04) and also cag A (p=0.04) was obtained in GC cases. However, vacAs1 was predominant (66.67%) in patients with GC, but with no significant association, which can be due to the low number of H. pylori positives cases in this group.. Vac Am1 and cag A genotypes were also predominant in SRCC which is a severe form of GC. Nevertheless, vacAs2m2 strains have been detected in 16% (n=4/25) of GC H.pylori positives cases. Those results let suppose that there are additional factors associated (virulence genes and environmental factors) to severe gastric epithelial damages and specially to GC. This hypothesis is strengthened by the low rate of GC comparatively to the very high rate of GA, which is considered as precancerous lesions [36].

In our series, high rate of glandular atrophy was observed when compared to that obtained in other African countries such as Kenya, Nigeria, Tunisia [21,37,38]. This raises a question about the factors implicated in this process. It’s known that H. pylori infection is generally contracted at early age. This acquisition in childhood associated [39] to the lower socioeconomic status, which prevents early diagnosis of infection, permits the persistence of this bacteria conducting to GA development. In our context, the rate of infection observed in adults aged <50 years (regardless of lesion), leads us to suppose that there is a high prevalence of infection in childhood. The persistence of this bacteria associated to environmental factors (or may be nutritional habits) leads to atrophy development. The environmental implication can be supported by the significant association of this lesion and also metaplasia with living area as observed in our studies (predominant in rural area). In other hand, and in spite of no significant association between H.pylori genotype and GA or IM in age group 1, the rate of less virulent genotypes in those lesions (s2 and m2 versus s1 and m1) was remarkable. This data can also support environmental implication or also, other genetic factors. To verify this hypothesis, a study on the prevalence of H.pylori infection in children, the implication of some nutritional and virulence factors are conducted in our region by our team.

This is the first large sampling prospective study aiming to determine the histopathological profile of H.pylori in infected patients and its correlation to vacA genotypes and cagA status in Moroccan patients. It’s also the first study to explore these associations according to the age. In spite of some limitations (Only biopsies from the antrum were used for genotyping analysis in each patient, some discordance between PCR and histological exam results (that must be explained)), this study showed significant association between cagA+ and NA in age group <50 years and with GC later in life (in age group > 50 years). Similarly, significant association was obtained between metaplasia and H. pylori vacA s1 and vacA m1 genotypes in age group 2. This last genotype is also associated to GC. This study let suppose that the occurrence of GC in our region is relatively high with no significant association with H.pylori. However, the role of other etiological agents such as EBV and HPV and possibly environmental and dietetic factors must be explored.

Acknowledgments

We would like to thank the staffs of the endoscopy unit and anatomo-pathology department for their help on specimen collection and preparation. We also thank Dr. Vanessa Garcia Larsen for the revision of this manuscript.

Author Contributions

Conceived and designed the experiments: BB AA DAB SAI CN MM AS. Performed the experiments: SAB AA MEK DAB. Analyzed the data: SAB KER BB. Contributed reagents/materials/analysis tools: BB SAI. Wrote the manuscript: SAB AA BB.

References

  1. 1. Parsonnet JFG, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N et al. (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325(16): 1127-1131. doi:https://doi.org/10.1056/NEJM199110173251603. PubMed: 1891020.
  2. 2. Kusters JG, van Vliet AH, Kuipers EJ (2006) Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 19(3): 449-490. doi:https://doi.org/10.1128/CMR.00054-05. PubMed: 16847081.
  3. 3. De Korwin JD, Lehours P (2010) Helicobacter pylori: notions fondamentales, épidémiologie, méthodes de diagnostic. Encyd Méd Chir: 1-16.
  4. 4. Atherton JC, Cao P, Peek RM Jr, Tummuru MK, Blaser MJ et al. (1995) Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 270(30): 17771-17777. doi:https://doi.org/10.1074/jbc.270.30.17771. PubMed: 7629077.
  5. 5. Dixon MF, Genta RM, Yardley JH, Correa P (1996) Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20(10):1161-81.
  6. 6. Boukhris SA, Bennajah D, El Rhazi K, Ibrahimi SA, Nejjari C et al. (2012) Prevalence and distribution of Helicobacter pylori cagA and vacA genotypes in the Moroccan population with gastric disease. Eur J Clin Microbiol Infect Dis 31: 1775–1781. doi:https://doi.org/10.1007/s10096-011-1501-x. PubMed: 22160824.
  7. 7. Lage AP, Godfroid E, Fauconnier A, Burette A, Butzler JP et al. (1995) Diagnosis of Helicobacter pylori infection by PCR: Comparison with other invasive techniques and detection of cagA gene in gastric biopsy specimens. J Clin Microbiol 33(10): 2752–2756. PubMed: 8567918.
  8. 8. Chattopadhyay S, Patra R, Ramamurthy T, Chowdhury A, Santra A et al. (2004) Multiplex PCR assay for rapid detection and genotyping of Helicobacter pylori directly from biopsy specimens. J Clin Microbiol 42 (6): 2821–2824. PubMed: 15184482.
  9. 9. Bolek BK, Salih BA, Sander E (2007) Genotyping of Helicobacter pylori strains from gastric biopsies by multiplex polymerase chain reaction. How advantageous is it? Diagn Microbiol Infect Dis 58(1): 67-70. doi:https://doi.org/10.1016/j.diagmicrobio.2006.12.001. PubMed: 17300903.
  10. 10. Ortiz-Princz D, Guariglia-Oropeza V, Avila M, Correnti M, Perrone M et al. (2010) Helicobacter pylori cagA and vacA genotypes in Cuban and Venezuelan populations. Mem Inst Oswaldo Cruz 105(3): 331-335. doi:https://doi.org/10.1590/S0074-02762010000300016. PubMed: 20512250.
  11. 11. Chung C, Olivares A, Torres E, Yilmaz O, Cohen H et al. (2010) Diversity of VacA intermediate region among Helicobacter pylori strains from several regions of the world. J Clin Microbiol 48(3): 690-696. doi:https://doi.org/10.1128/JCM.01815-09. PubMed: 20053862.
  12. 12. de Martel C, Plummer M, van Doorn LJ, Vivas J, Lopez G et al. (2010) Comparison of polymerase chain reaction and histopathology for the detection of Helicobacter pylori in gastric biopsies. Int J Cancer 126(8): 1992-1996. PubMed: 19795444.
  13. 13. Kisa O, Albay A, Mas MR, Celasun B, Doganci L (2002) The evaluation of diagnostic methods for the detection of Helicobacter pylori in gastric biopsy specimens. Diagn Microbiol Infect Dis 43(4): 251-255. doi:https://doi.org/10.1016/S0732-8893(02)00409-1. PubMed: 12151183.
  14. 14. Lunet N, Peleteiro B, Carrilho C, Figueiredo C, Azevedo A (2009) Sensitivity is not an intrinsic property of a diagnostic test: empirical evidence from histological diagnosis of Helicobacter pylori infection. BMC Gastroenterol 9: 98. doi:https://doi.org/10.1186/1471-230X-9-98. PubMed: 20034390.
  15. 15. Shukla SK, Prasad KN, Tripathi A, Ghoshal UC, Krishnani N et al. (2011) Quantitation of Helicobacter pylori ureC gene and its comparison with different diagnostic techniques and gastric histopathology. J Microbiol Methods 86(2): 231-237. doi:https://doi.org/10.1016/j.mimet.2011.05.012. PubMed: 21624400.
  16. 16. IARC (1994) Monographs on the evaluation of carcinogenic risks to humans. liver flukes and Helicobacter pylori.schistosomes Lyon,France. p. 61.
  17. 17. Nogueira C, Figueiredo C, Carneiro F, Gomes AT, Barreira R et al. (2001) Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol 158(2): 647-654. doi:https://doi.org/10.1016/S0002-9440(10)64006-0. PubMed: 11159201.
  18. 18. Soltermann A, Koetzer S, Eigenmann F, Komminoth P (2007) Correlation of Helicobacter pylori virulence genotypes vacA and cagA with histological parameters of gastritis and patient's age. Mod Pathol 20(8): 878-883. doi:https://doi.org/10.1038/modpathol.3800832. PubMed: 17541440.
  19. 19. Scholte GH, van Doorn LJ, Cats A, Bloemena E, Lindeman J et al. (2002) Genotyping of H. pylori in paraffin-embedded gastric biopsy specimens: relation to histological parameters and effects on therapy. A m. J Gastroenterol 97(7): 1687-1695.
  20. 20. Khedmat H, Karami A, Safiri Z, Amini M, Bakhtiari A et al. (2012) Helicobacter pylori genotypes can predict gastric tissue histopathology: a longitudinal study of Iranian patients. J Infect Public Health 5(2): 153-158. doi:https://doi.org/10.1016/j.jiph.2011.10.009. PubMed: 22541262.
  21. 21. Kalebi A, Rana F, Mwanda W, Lule G, Hale M (2007) Histopathological profile of gastritis in adult patients seen at a referral hospital in Kenya. World J Gastroenterol 13(30): 4117-4121. PubMed: 17696233.
  22. 22. Plummer M, van Doorn LJ, Franceschi S, Kleter B, Canzian F et al. (2007) Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions. J Natl Cancer Inst 99(17): 1328-1334. doi:https://doi.org/10.1093/jnci/djm120. PubMed: 17728213.
  23. 23. Zhang C, Yamada N, Wu YL, Wen M, Matsuhisa T et al. (2005) Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer.World J Gastroenterol 11(6): 791-796. PubMed: 15682469.
  24. 24. Lima VP, Silva-Fernandes IJ, Alves MK, Rabenhorst SH (2011) Prevalence of Helicobacter pylori genotypes (vacA, cagA, cagE and virB11) in gastric cancer in Brazilian's patients: an association with histopathological parameters. Cancer Epidemiol 35(5): 32-37. doi:https://doi.org/10.1016/j.canep.2011.02.017. PubMed: 21470935.
  25. 25. Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118(12): 3030-3044. doi:https://doi.org/10.1002/ijc.21731. PubMed: 16404738.
  26. 26. Elzouki AN, Buhjab S, Alkialani A, Habel S, Sasco AJ (2012) Gastric cancer and Helicobacter pylori infection in the eastern Libya: a descriptive epidemiological study. Arab. J Gastroenterol 13(2): 85-88.
  27. 27. Fukayama M (2010) Epstein-Barr virus and gastric carcinoma. Pathol Int 60 (5): 337-350. doi:https://doi.org/10.1111/j.1440-1827.2010.02533.x. PubMed: 20518883.
  28. 28. Fukayama M (2012) Epstein-Barr virus and gastric carcinoma. Nihon Rinshom 70(10): 1715-1719.
  29. 29. Luo B, Wang Y, Wang XF, Liang H, Yan LP et al. (2005) Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas.World J Gastroenterol 11(5): 629-633. PubMed: 15655811.
  30. 30. Luo B, Wang Y, Wang XF, Gao Y, Huang BH et al. (2006) Correlation of Epstein-Barr virus and its encoded proteins with Helicobacter pylori and expression of c-met and c-myc in gastric carcinoma.World J Gastroenterol 12(12): 1842-1848. PubMed: 16609989.
  31. 31. Shukla SK, Prasad KN, Tripathi A, Singh A, Saxena A et al. (2011) Epstein-Barr virus DNA load and its association with Helicobacter pylori infection in gastroduodenal diseases. Braz J Infect Dis 15(6): 583-590. doi:https://doi.org/10.1016/S1413-8670(11)70255-0. PubMed: 22218519.
  32. 32. Shukla S, Bharti AC, Mahata S, Hussain S, Kumar R et al. (2009) Infection of human papillomaviruses in cancers of different human organ sites. Indian J Med Res 130(3): 222-233. PubMed: 19901431.
  33. 33. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM et al. (1995) Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55: 2111-2115. PubMed: 7743510.
  34. 34. Audibert C, Burucoa C, Janvier B, Fauchère JL (2001) Implication of the structure of the Helicobacter pylori cag pathogenicity island in induction of interleukin-8 secretion. Infect Immun 69(3): 1625-1629. doi:https://doi.org/10.1128/IAI.69.3.1625-1629.2001. PubMed: 11179336.
  35. 35. Kuipers EJ, Pérez-Pérez GI, Meuwissen SG, Blaser MJ (1995) Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 87(23): 1777-1780. doi:https://doi.org/10.1093/jnci/87.23.1777. PubMed: 7473834.
  36. 36. MacDonald WC, Owen DA (1991) Chronic atrophic gastritis, intestinal metaplasia of the stomach and partial gastrectomy. In: GI Eastwood. Premalignant conditions of the gastrointestinal tract. Elsevier: New York. p. 145.
  37. 37. Badmos KB, Ojo OS, Olasode OS, Arigbabu AO (2009) Gastroduodenitis and Helicobacter pylori in Nigerians: histopathological assessment of endoscopic biopsies. Niger Postgrad Med J 16: 264–267. PubMed: 20037622.
  38. 38. Jmaa R, Aissaoui B, Golli L, Jmaa A, Al QJ et al. ( 2010) The particularity of Helicobacter pylori chronic gastritis in the west centre of Tunisia. Tunis Med 88: 147–151. PubMed: 20415185.
  39. 39. Mitchell HM, Hu P, Chi Y, Chen MH, Li YY et al. (1998) A low rate of reinfection following effective therapy against Helicobacter pylori in a developing nation (China). Gastroenterology 114(2): 256-261. doi:https://doi.org/10.1016/S0016-5085(98)70475-5. PubMed: 9453484.